
Sign up to save your podcasts
Or


Send us a text
Dr. Stein Gold discusses insights from clinical trials on new and upcoming systemic agents for psoriasis, including deucravacitinib and bimekizumab.
By Matrix Medical Communications5
22 ratings
Send us a text
Dr. Stein Gold discusses insights from clinical trials on new and upcoming systemic agents for psoriasis, including deucravacitinib and bimekizumab.

550 Listeners

2 Listeners

33 Listeners